Trinity Biotech regains Nasdaq minimum bid price compliance

• Trinity Biotech regained compliance with Nasdaq’s $1 minimum bid price rule following 10 consecutive business days above $1.
• Nasdaq confirmed compliance on Aug. 7, 2026, covering the period from July 24, 2026 through Aug. 6, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trinity Biotech plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608140932PRIMZONEFULLFEED9810374) on August 14, 2026, and is solely responsible for the information contained therein.